INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 196 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $7,441,000 | -33.9% | 118,188 | +30.2% | 1.28% | -1.2% |
Q4 2019 | $11,252,000 | +5.1% | 90,804 | -43.7% | 1.29% | +40.5% |
Q3 2019 | $10,711,000 | -48.8% | 161,406 | -22.3% | 0.92% | -47.0% |
Q4 2018 | $20,930,000 | -29.3% | 207,657 | -11.3% | 1.74% | +8.8% |
Q3 2018 | $29,585,000 | -8.8% | 234,135 | -39.4% | 1.60% | -10.5% |
Q2 2018 | $32,423,000 | +51.2% | 386,397 | +10.9% | 1.78% | +42.5% |
Q1 2018 | $21,437,000 | – | 348,454 | – | 1.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |